Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacology and Therapeutics | journal | 3.668 Q1 | 233 | 108 | 306 | 19821 | 3151 | 302 | 9.47 | 183.53 | 30.12 | |
2 | Drug Metabolism Reviews | journal | 1.556 Q1 | 108 | 18 | 103 | 2906 | 568 | 99 | 5.25 | 161.44 | 28.07 | |
3 | Drug Resistance Updates | journal | 3.276 Q1 | 132 | 26 | 62 | 3117 | 625 | 60 | 10.17 | 119.88 | 20.90 | |
4 | Expert Opinion on Emerging Drugs | journal | 0.898 Q2 | 54 | 44 | 137 | 4301 | 471 | 137 | 3.09 | 97.75 | 36.52 | |
5 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 23 | 2 | 1 | 192 | 0 | 1 | 0.00 | 96.00 | 45.45 | |
6 | Neurotherapeutics | journal | 2.526 Q1 | 136 | 67 | 196 | 6383 | 1363 | 182 | 6.98 | 95.27 | 39.84 | |
7 | Review of Clinical Pharmacology and Pharmacokinetics, International Edition | journal | 0.102 Q4 | 9 | 5 | 110 | 444 | 3 | 109 | 0.03 | 88.80 | 50.00 | |
8 | Frontiers in Pharmacology | journal | 0.717 Q2 | 154 | 206 | 129 | 17703 | 312 | 125 | 2.42 | 85.94 | 41.23 | |
9 | Journal of International Peacekeeping | journal | 0.138 Q4 | 14 | 15 | 50 | 1222 | 21 | 47 | 0.34 | 81.47 | 38.10 | |
10 | Open Neuropsychopharmacology Journal | journal | 0.183 Q3 | 6 | 3 | 20 | 238 | 11 | 19 | 0.38 | 79.33 | 31.25 | |
11 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.394 Q2 | 30 | 27 | 81 | 2124 | 126 | 80 | 1.75 | 78.67 | 16.28 | |
12 | Expert Opinion on Investigational Drugs | journal | 1.486 Q1 | 117 | 161 | 456 | 12444 | 2063 | 446 | 4.32 | 77.29 | 34.72 | |
13 | Clinical Pharmacokinetics | journal | 2.254 Q1 | 184 | 56 | 179 | 4291 | 1219 | 160 | 7.01 | 76.63 | 37.37 | |
14 | AIDS Reviews | journal | 1.661 Q1 | 62 | 32 | 79 | 2447 | 307 | 61 | 3.42 | 76.47 | 27.66 | |
15 | CNS Drugs | journal | 1.921 Q1 | 129 | 78 | 240 | 5960 | 1539 | 224 | 5.97 | 76.41 | 36.56 | |
16 | Side Effects of Drugs Annual | book series | 0.102 Q4 | 9 | 53 | 157 | 4034 | 4 | 53 | 0.02 | 76.11 | 0.00 | |
17 | Drugs | journal | 1.615 Q1 | 188 | 158 | 463 | 11728 | 2799 | 449 | 6.13 | 74.23 | 34.18 | |
18 | Biologics: Targets and Therapy | journal | 0.845 Q2 | 47 | 46 | 67 | 3347 | 202 | 66 | 3.11 | 72.76 | 44.37 | |
19 | BioDrugs | journal | 1.106 Q1 | 79 | 42 | 130 | 3053 | 546 | 127 | 3.62 | 72.69 | 35.58 | |
20 | PPAR Research | journal | 0.830 Q2 | 59 | 86 | 117 | 5992 | 312 | 110 | 2.90 | 69.67 | 38.20 | |
21 | Expert Opinion on Drug Safety | journal | 1.003 Q1 | 90 | 95 | 237 | 6568 | 767 | 230 | 3.15 | 69.14 | 33.33 | |
22 | Current Psychopharmacology | journal | 4 | 1 | 0 | 69 | 0 | 0 | 0.00 | 69.00 | 66.67 | ||
23 | Expert Review of Neurotherapeutics | journal | 1.157 Q1 | 98 | 147 | 495 | 9948 | 1749 | 431 | 3.08 | 67.67 | 31.23 | |
24 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 0.638 Q2 | 47 | 32 | 4 | 2137 | 6 | 3 | 1.50 | 66.78 | 33.33 | |
25 | Journal of Dietary Supplements | journal | 0.138 Q4 | 38 | 25 | 86 | 1637 | 29 | 84 | 0.43 | 65.48 | 56.86 | |
26 | Expert Opinion on Pharmacotherapy | journal | 0.756 Q2 | 93 | 251 | 812 | 16233 | 2240 | 780 | 2.71 | 64.67 | 33.33 | |
27 | Methods in Pharmacology and Toxicology | book series | 14 | 44 | 0 | 2818 | 0 | 0 | 0.00 | 64.05 | 32.29 | ||
28 | Journal of Psychopharmacology | journal | 1.443 Q1 | 135 | 176 | 525 | 11248 | 1996 | 489 | 3.75 | 63.91 | 38.18 | |
29 | Current Cardiovascular Risk Reports | journal | 0.285 Q3 | 34 | 75 | 203 | 4704 | 107 | 201 | 0.60 | 62.72 | 48.99 | |
30 | Cardiovascular Therapeutics | journal | 1.009 Q1 | 54 | 74 | 153 | 4591 | 437 | 143 | 2.79 | 62.04 | 33.33 | |
31 | Expert Review of Anticancer Therapy | journal | 0.875 Q2 | 85 | 157 | 564 | 9329 | 1383 | 494 | 2.24 | 59.42 | 31.36 | |
32 | International Journal of Neuropsychopharmacology | journal | 2.131 Q1 | 125 | 127 | 377 | 7517 | 1865 | 359 | 4.78 | 59.19 | 41.38 | |
33 | Therapeutic Advances in Drug Safety | journal | 0.209 Q3 | 46 | 24 | 30 | 1392 | 19 | 25 | 0.63 | 58.00 | 33.85 | |
34 | Inflammopharmacology | journal | 0.529 Q2 | 68 | 36 | 98 | 2083 | 249 | 95 | 1.82 | 57.86 | 41.28 | |
35 | Current Treatment Options in Oncology | journal | 1.039 Q1 | 66 | 41 | 73 | 2300 | 261 | 71 | 3.23 | 56.10 | 39.81 | |
36 | Expert Review of Clinical Pharmacology | journal | 0.365 Q3 | 60 | 79 | 195 | 4432 | 237 | 171 | 1.38 | 56.10 | 32.47 | |
37 | Paediatric Drugs | journal | 0.621 Q2 | 70 | 45 | 132 | 2496 | 290 | 123 | 2.19 | 55.47 | 42.02 | |
38 | Journal of Psychiatry and Neuroscience | journal | 3.346 Q1 | 114 | 47 | 150 | 2531 | 910 | 123 | 5.02 | 53.85 | 41.41 | |
39 | Drug Target Insights | journal | 0.283 Q3 | 16 | 4 | 3 | 209 | 3 | 3 | 0.50 | 52.25 | 31.25 | |
40 | Therapeutic Advances in Cardiovascular Disease | journal | 0.624 Q2 | 41 | 20 | 103 | 1043 | 247 | 94 | 2.65 | 52.15 | 25.00 | |
41 | OncoTargets and Therapy | journal | 0.805 Q2 | 86 | 51 | 64 | 2641 | 152 | 64 | 3.12 | 51.78 | 37.08 | |
42 | Experimental and Clinical Psychopharmacology | journal | 1.472 Q1 | 101 | 57 | 150 | 2870 | 525 | 150 | 3.05 | 50.35 | 45.59 | |
43 | Clinical Psychopharmacology and Neuroscience | journal | 0.153 Q3 | 42 | 25 | 62 | 1256 | 11 | 58 | 0.18 | 50.24 | 33.33 | |
44 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 30 | 29 | 1504 | 63 | 29 | 2.36 | 50.13 | 29.63 | ||
45 | Cancer and Chemotherapy Reviews | journal | 0.104 Q4 | 4 | 19 | 58 | 946 | 4 | 58 | 0.08 | 49.79 | 55.81 | |
46 | Therapeutics and Clinical Risk Management | journal | 0.516 Q2 | 70 | 47 | 127 | 2311 | 281 | 127 | 2.27 | 49.17 | 28.40 | |
47 | Drugs and Aging | journal | 0.975 Q1 | 109 | 98 | 263 | 4816 | 987 | 250 | 3.54 | 49.14 | 39.93 | |
48 | Orphanet Journal of Rare Diseases | journal | 1.970 Q1 | 136 | 112 | 158 | 5476 | 1049 | 157 | 5.80 | 48.89 | 46.88 | |
49 | Drug and Alcohol Dependence | journal | 1.794 Q1 | 187 | 324 | 822 | 15795 | 3282 | 798 | 3.50 | 48.75 | 47.12 | |
50 | Drug Metabolism and Personalized Therapy | journal | 0.276 Q3 | 38 | 32 | 50 | 1549 | 59 | 47 | 0.94 | 48.41 | 47.59 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®